Panel Weighs Sale of Pediatric Medicines
533363
A panel of federal drug advisers began a two-day meeting to decide whether over-the-counter pediatric cough and cold medicines should continue to be sold.
93100
U.S. health regulators said on  Friday they have been reviewing the safety of over-the-counter  children's cough and cold medications, especially for those  under age 2.
738728
FRIDAY, Oct. 19 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel on Friday recommended a ban on over-the-counter cough and cold medicines for children younger than 6.
615089
AUSTIN -- Texas Comptroller Carole Keeton Strayhorn is investigating foster care and possible Medicaid prescription drug fraud. Strayhorn said Texas is spending about $4 million per year on mind-altering drugs for foster care children.
384208
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:    -----       Hearings Begin on Antidepressant Use in Children      Two U.S. Food and Drug Administration advisory panels opened hearings Monday on the controversial issue of prescribing antidepressants for children...
494061
BETHESDA, Md.  - A U.S. advisory panel on Friday  urged regulators to reject over-the-counter sales of Merck &  Co. Inc.'s MRK.N cholesterol-lowering drug Mevacor.
284385
Common children's cold and cough medicines are coming under scrutiny from federal drug regulators, who say the remedies and their recommended doses have not been studied enough in children
612039
Manufacturers should  conduct clinical studies to show that over-the-counter cough  and cold medicines are effective in children less than 12 years  old, a U.S. advisory panel said on Friday.
303984
At least five medications now sold to consumers pose such risks that their sale should be limited or stopped, said a government drug reviewer who raised safety questions earlier about the arthritis drug Vioxx.
757776
The American Medical Association is weighing support of importing prescription drugs from outside the United States as the nation&#39;s physicians address pleas from patients over the high cost of medicines.
417991
The discovery that antidepressants may increase suicidal tendencies in children has prompted some lawmakers and physicians to ask if changes are needed to financial incentives given to drug makers for pediatric research.
308347
BETHESDA, Md.  - A U.S. advisory panel began  meeting Monday to debate whether certain antidepressants should  come with stronger warnings about the chances of suicidal  behavior in children and teens who take the drugs.
673626
The discovery that antidepressants may increase suicidal tendencies in children  has prompted some lawmakers and physicians to ask if changes are needed to financial incentives given to drug makers for pediatric research.
265165
A second Food and Drug Administration advisory committee agreed that healthy children as young as 9 could be given the stimulant dextroamphetamine in an experiment, concurring with an ethics panel&#39;s recommendation last week.
379737
Federal advisers who met last week to consider whether to restrict doses of popular antianemia drugs were themselves under scrutiny during the hearing. The Food and Drug Administration is considering a top-to-bottom reshaping of how it picks and uses the outside scientists who serve on the agency's advisory panels.
135212
FDA could make a decision within days on whether to adopt an advisory panel&#39;s recommendations to include a black box warning about the increased risk of suicidal tendencies that antidepressants pose for children, and any labeling changes could be
570747
More patients with serious diseases could get experimental drugs under revised rules proposed on Monday by the U.S. Food and Drug Administration that also detail how manufacturers can charge for them.